Ajay Major
32PUBLICATIONS
213CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (32)
Sort by Publication Date:
|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan
|Jul 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab.Taylor R Brooks, Emily C Zabor, Yohanna B Bedelu
|Apr 15, 2025
Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis.Y Sawalha, S Sarosiek, R L Welkie
|Mar 27, 2025
Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers.Timothy J Voorhees, Eric M McLaughlin, Pallawi Torka
|Mar 10, 2025
Patient and care partner perspectives on treatment decision-making in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): a Global nLPHL One Working Group (GLOW) study.Ajay Major, Monica Palese, Anna Jones
Pageof 6
Frequent Collaborators
4 joint publications
Pallawi Torka
3 joint publications
Jamie Flerlage
3 joint publications
Thomas A Ollila
3 joint publications
Natalie Sophia Grover
3 joint publications
Narendranath Epperla
3 joint publications
Michael Sargent Binkley
2 joint publications
Christopher L Carroll
2 joint publications
Annina Elisabeth Büchi
2 joint publications
Darcy Burbage
2 joint publications
Natasha Abadilla